Infection
Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010–2019)
Jul
Dean SG, Ricotta EE, Fintzi J, Lai YL, Kadri SS, Olivier KN, et al. Mycobacterial testing Trends, United States, 2009–2015(1). Emerg Infect Dis. 2020;26(9):2243–6.
Google Scholar
Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of Nontuberculous Mycobacterial Lung Disease in a large U.S. Managed Care Health Plan, 2008–2015. Ann Am Thorac Soc. 2020;17(2):178–85.
Google Scholar
Adjemian J, Olivier KN, Prevots DR. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum positivity in patients with cystic fibrosis in the United States, 2010–2014. Annals of the American Thoracic Society. 2018;15(7):817–26.
Google Scholar
Esther CR Jr, Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros. 2010;9(2):117–23.
Google Scholar
Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med. 2003;167(6):835–40.
Google Scholar
Floto RA, Kenneth NO, Lisa S, Charles LD, Jean-Louis H, Jerry AN, et al. US cystic Fibrosis Foundation and european cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71(Suppl 1):i1.
Google Scholar
Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C, et al. The cystic Fibrosis Foundation Patient Registry. Design and methods of a National Observational Disease Registry. Ann Am Thorac Soc. 2016;13(7):1173–9.
Google Scholar
United States. ZIP Code Database.
Team RC. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021.
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535.
Google Scholar
Ricotta EE, Prevots DR, Olivier KN. CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018. ERJ Open Res. 2022;8(2).
Martiniano SL, Nick JA, Daley CL. Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med. 2022;43(4):697–716.
Google Scholar
Spaulding AB, Lai YL, Zelazny AM, Olivier KN, Kadri SS, Prevots DR, et al. Geographic distribution of Nontuberculous Mycobacterial Species identified among clinical isolates in the United States, 2009–2013. Ann Am Thorac Soc. 2017;14(11):1655–61.
Google Scholar
Foote SL, Lipner EM, Prevots DR, Ricotta EE. Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida. PLoS ONE. 2021;16(12):e0259964.
Google Scholar
Lipner EM, Crooks JL, French J, Strong M, Nick JA, Prevots DR. Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case-control study in Colorado. J Expo Sci Environ Epidemiol. 2022;32(2):289–94.
Google Scholar
Lipner EM, French JP, FalkinhamIII JO, Crooks JL, Mercaldo RA, Henkle E, et al. Nontuberculous mycobacteria infection risk and Trace Metals in Surface Water: a Population-based ecologic epidemiologic study in Oregon. Annals of the American Thoracic Society. 2022;19(4):543–50.
Google Scholar
DeFlorio-Barker S, Egorov A, Smith GS, Murphy MS, Stout JE, Ghio AJ, et al. Environmental risk factors associated with pulmonary isolation of nontuberculous mycobacteria, a population-based study in the southeastern United States. Sci Total Environ. 2021;763:144552.
Google Scholar
Lipner EM, French JP, Nelson S, Falkinham Iii JO, Mercaldo RA, Blakney RA, et al. Vanadium in groundwater aquifers increases the risk of MAC pulmonary infection in O’ahu, Hawai’i. Environ Epidemiol. 2022;6(5):e220.
Google Scholar
Adjemian J, Olivier KN, Seitz AE, Falkinham JO 3rd, Holland SM, Prevots DR. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med. 2012;186(6):553–8.
Google Scholar
